[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![HighSell53466 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1937749820602753024.png) Buy High Sell Low [@HighSell53466](/creator/twitter/HighSell53466) on x XXX followers
Created: 2025-07-19 16:25:08 UTC

$VKTX is going after liver and obesity targets with its novel therapies, aiming to disrupt $NVO and $LLY’s dominance.

While $NVO and $LLY bank on proven injectable GLP-1 drugs, $VKTX bets on oral delivery and combo therapies.

Smaller, leaner, and riskier—but if trials succeed, the payoff could be enormous.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946607246416203807/c:line.svg)

**Related Topics**
[combo](/topic/combo)
[drugs](/topic/drugs)
[$lly](/topic/$lly)
[dominance](/topic/dominance)
[$llys](/topic/$llys)
[$vktx](/topic/$vktx)
[$nvo](/topic/$nvo)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/HighSell53466/status/1946607246416203807)